VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2011

Feb 9, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2011-02-07

Reporting Person: BOGER JOSHUA S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-07	Common Stock	G	39000	—	Disposed	727395	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13286	Indirect
Common Stock	207500	Indirect
Common Stock	300000	Indirect

Footnotes

F1: Common stock given to family members.

F2: Common stock held in a grantor retained annuity trust.